AngioDynamics Inc (ANGO) stock
ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 12/308% below fair value
$11.87−0.12 (-0.96%)
Close on Nov 13, 2026Market cap $499.19MP/E –Yield –
AngioDynamics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
AngioDynamics's operating cash flow for the twelve months ending Aug 31, 2026 was $3.67M. For fiscal 2026 it was $3.09M. Over ten years it grew -23.5% a year on average. The highest annual figure on record is $55.75M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | $3.09M | – |
| FY2025 | May 31, 2025 | -$10.13M | – |
| FY2024 | May 31, 2024 | -$28.16M | -36200.0% |
| FY2023 | May 31, 2023 | $78.00K | – |
| FY2022 | May 31, 2022 | -$7.19M | -129.9% |
| FY2021 | May 31, 2021 | $24.09M | – |
| FY2020 | May 31, 2020 | -$14.55M | -138.9% |
| FY2019 | May 31, 2019 | $37.44M | -9.3% |
| FY2018 | May 31, 2018 | $41.29M | -25.9% |
| FY2017 | May 31, 2017 | $55.75M | +23.3% |
| FY2016 | May 31, 2016 | $45.22M | +76.0% |
| FY2015 | May 31, 2015 | $25.69M | +4.1% |
| FY2014 | May 31, 2014 | $24.68M | -7.4% |
| FY2013 | May 31, 2013 | $26.65M | +129.7% |
| FY2012 | May 31, 2012 | $11.60M | -65.7% |
| FY2011 | May 31, 2011 | $33.87M | -15.2% |
| FY2010 | May 31, 2010 | $39.96M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -$15.33M | – |
| Q4 FY2026CQ2 2026 | May 31, 2026 | $17.45M | -7.2% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -$3.11M | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $4.66M | +88.5% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$15.91M | – |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $18.81M | +276.1% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$13.16M | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $2.47M | -53.0% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -$18.25M | – |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $5.00M | -68.7% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$12.53M | -1014.3% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $5.27M | -29.8% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -$25.90M | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $15.95M | +86.4% |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $1.37M | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $7.50M | +286.3% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -$24.75M | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | $8.56M | -29.8% |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -$8.79M | -249.7% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | $1.94M | -83.0% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$8.90M | – |
| Q4 FY2021CQ2 2021 | May 31, 2021 | $12.20M | +214.4% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $5.87M | – |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $11.45M | +92.8% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | -$5.43M | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $3.88M | -84.5% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | -$17.84M | -313.8% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $5.94M | -54.2% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | -$6.53M | – |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $25.01M | +5.2% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $8.34M | +93.3% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | $12.96M | +27.5% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | -$8.87M | -392.3% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | $23.77M | +25.2% |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $4.32M | -70.0% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $10.17M | -32.0% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | $3.04M | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | $18.99M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $14.37M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $14.95M | – |
See a number that looks wrong?